Biomarkers in whichever modality are tremendously important in diagnosing of disease,
tracking disease progression and clinical trials. This applies in particular for disorders with a …

Parkinson disease (PD) is characterized by heterogeneous motor and non-motor symptoms,
resulting from neurodegeneration involving various parts of the central nervous system …

Noradrenergic and cholinergic systems are among the most vulnerable brain systems in
neuropsychiatric diseases of ageing, including Alzheimer's disease, Parkinson's disease …

Introduction The cerebellum has strong cortical and subcortical connectivity, but is rarely
taken into account for clinical diagnosis in many neurodegenerative conditions, particularly …

Rapid reconfigurations of brain activity support efficient neuronal communication and
flexible behaviour. Suboptimal brain dynamics is associated to impaired adaptability …

Aims Parkinson's disease (PD) is the second most prevalent age‐related neurodegenerative
disorder. The cerebellum plays a role in PD pathogenesis. Curcumin has numerous …

Parkinson's disease (PD) is one of the most common progressive degenerative diseases,
and its diagnosis is challenging on clinical grounds. Clinically, effective and quantifiable …

Parkinson's disease (PD) patients can be classified in tremor-dominant (TD) and postural-
instability-and-gait-disorder (PIGD) motor subtypes. PIGD represents a more aggressive …

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by both
motor and non‐motor symptoms. A convergent pathophysiological hallmark of PD is an early …

Mind wandering represents the human capacity for internally focused thought and relies
upon the brain's default network and its interactions with attentional networks. Studies have …